BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19463575)

  • 21. Early ligation of the pulmonary vein can reduce the dissemination of shed tumor cells during thoracoscopic lobectomy.
    Duan X; Yang Z; Hao X; Zhou S; Liu Z; Zhang K; Cui Y
    J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1623-1635.e2. PubMed ID: 35589423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.
    Kahn HJ; Presta A; Yang LY; Blondal J; Trudeau M; Lickley L; Holloway C; McCready DR; Maclean D; Marks A
    Breast Cancer Res Treat; 2004 Aug; 86(3):237-47. PubMed ID: 15567940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer.
    Vona G; Estepa L; Béroud C; Damotte D; Capron F; Nalpas B; Mineur A; Franco D; Lacour B; Pol S; Bréchot C; Paterlini-Bréchot P
    Hepatology; 2004 Mar; 39(3):792-7. PubMed ID: 14999698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2-40-positive lymphatic vessel density is a poor prognostic factor in squamous cell carcinoma of the lung.
    Iwakiri S; Nagai S; Katakura H; Takenaka K; Date H; Wada H; Tanaka F
    Ann Surg Oncol; 2009 Jun; 16(6):1678-85. PubMed ID: 19330380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive correlation between postoperative tumor recurrence and changes in circulating tumor cell counts in pulmonary venous blood (pvCTC) during surgical manipulation in non-small cell lung cancer.
    Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsujimura T; Nakano T; Hasegawa S
    J Thorac Dis; 2018 Jan; 10(1):298-306. PubMed ID: 29600060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
    Budd GT
    Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
    Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
    J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood.
    Wind J; Tuynman JB; Tibbe AG; Swennenhuis JF; Richel DJ; van Berge Henegouwen MI; Bemelman WA
    Eur J Surg Oncol; 2009 Sep; 35(9):942-50. PubMed ID: 19153024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility.
    Liu Z; Jiang M; Zhao J; Ju H
    Clin Cancer Res; 2007 May; 13(10):2992-7. PubMed ID: 17505001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary metastasis from primary lung cancer and its treatment].
    Furuse K; Kawahara M; Arai R; Turuta S; Konnai Y; Yamamoto S; Hashimoto T
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):964-71. PubMed ID: 6307187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cell as a diagnostic marker in primary lung cancer.
    Tanaka F; Yoneda K; Kondo N; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Rahman S; Tsubota N; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
    Clin Cancer Res; 2009 Nov; 15(22):6980-6. PubMed ID: 19887487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cells predict survival in patients with metastatic prostate cancer.
    Moreno JG; Miller MC; Gross S; Allard WJ; Gomella LG; Terstappen LW
    Urology; 2005 Apr; 65(4):713-8. PubMed ID: 15833514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer.
    Kreusel KM; Bechrakis NE; Wiegel T; Krause L; Foerster MH
    Acta Ophthalmol; 2008 Aug; 86(5):515-9. PubMed ID: 18081901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
    Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
    J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compartmental differences of circulating tumor cells in colorectal cancer.
    Rahbari NN; Bork U; Kircher A; Nimitz T; Schölch S; Kahlert C; Schmidt T; Steinert G; Ulrich AB; Reissfelder C; Büchler MW; Koch M; Weitz J
    Ann Surg Oncol; 2012 Jul; 19(7):2195-202. PubMed ID: 22230943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.
    Murlidhar V; Reddy RM; Fouladdel S; Zhao L; Ishikawa MK; Grabauskiene S; Zhang Z; Lin J; Chang AC; Carrott P; Lynch WR; Orringer MB; Kumar-Sinha C; Palanisamy N; Beer DG; Wicha MS; Ramnath N; Azizi E; Nagrath S
    Cancer Res; 2017 Sep; 77(18):5194-5206. PubMed ID: 28716896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence.
    Yalcin S; Kilickap S; Portakal O; Arslan C; Hascelik G; Kutluk T
    Hepatogastroenterology; 2010; 57(104):1395-8. PubMed ID: 21443092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.